Showing results (1931-1940 of 2,042) with videos related to

Sort By:
Pageof 205
ALTEX|November 1, 2024
Corrigendum to Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 23, 2012
Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients?R Zachariah, A D Harries, S Srinath, et al.
The Review of Scientific Instruments|July 2, 2018
The Heidelberg compact electron beam ion trapsP Micke, S Kühn, L Buchauer, et al.
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 26, 2023
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panelManuela Harries, Veronika K Jaeger, Isti Rodiah, et al.
Oncoimmunology|October 10, 2015
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaPanagiotis Karagiannis, Federica Villanova, Debra H Josephs, et al.
Plos One|September 29, 2017
Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteersLuke C Pilling, Janice L Atkins, Michael O Duff, et al.
Oncotarget|October 10, 2015
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancerJennifer Munkley, Sebastian Oltean, Daniel Vodák, et al.
Nature|May 23, 2000
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesiaJ B Davis, J Gray, M J Gunthorpe, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
Pageof 205